IMPROVED AORTOCORONARY BYPASS PATENCY BY LOW-DOSE ASPIRIN (100 mg DAILY)
Open Access
- 1 June 1984
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 323 (8389), 1261-1264
- https://doi.org/10.1016/s0140-6736(84)92446-2
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Coronary bypass surgery for chronic angina--1981. A perspective.Circulation, 1982
- DIFFERENTIAL INHIBITION OF PROSTACYCLIN PRODUCTION AND PLATELET AGGREGATION BY ASPIRINThe Lancet, 1979
- Prevention of Thrombosis in Patients on Hemodialysis by Low-Dose AspirinNew England Journal of Medicine, 1979
- Reduction of intimal thickening in canine coronary bypass vein grafts with dipyridamole and aspirinThe American Journal of Cardiology, 1979
- ASPIRIN: A PARADOXICAL EFFECT ON BLEEDING-TIMEThe Lancet, 1978
- ASPIRIN, THROMBOXANE, AND PROSTACYCLIN IN RATS: A DILEMMA RESOLVED?The Lancet, 1978
- Vein graft patency and intimal proliferation after aortocoronary bypass: Early and long-term angiopathologic correlationsThe American Journal of Cardiology, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Correlation of platelet survival time with occlusion of saphenous vein aorto-coronary bypass grafts.Circulation, 1976
- Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.Proceedings of the National Academy of Sciences, 1975